SAVA
NASDAQ · Pharmaceuticals
Cassava Sciences Inc
$1.85
-0.03 (-1.60%)
Open$1.85
Previous Close$1.88
Day High$1.88
Day Low$1.82
52W High$4.98
52W Low$1.15
Volume—
Avg Volume728.3K
Market Cap114.97M
P/E Ratio—
EPS$-2.20
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+727.0% upside
Current
$1.85
$1.85
Target
$15.30
$15.30
$10.17
$15.30 avg
$19.74
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 22.84M | 20.47M | 21.96M |
| Net Income | 4.14M | 5.17M | 4.25M |
| Profit Margin | 18.1% | 25.2% | 19.3% |
| EBITDA | 7.09M | 5.98M | 7.27M |
| Free Cash Flow | 3.09M | 2.63M | 3.14M |
| Rev Growth | -6.9% | +1.2% | +18.5% |
| Debt/Equity | 1.35 | 1.36 | 1.39 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |